A global call for talaromycosis to be recognised as a neglected tropical diseaseShanti Narayanasamy, Thuy Le, Vu Quoc Dat et al.|The Lancet Global Health|2021Cited by 143
Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trialsChloe Orkin, Christine Katlama, Khuanchai Supparatpinyo et al.|The Lancet HIV|2023Cited by 31